Global Benign Prostatic Hyperplasia Treatment Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Benign Prostatic Hyperplasia Treatment Market Expected To Grow In Terms Of Size?
In recent times, the market size for the treatment of benign prostatic hyperplasia has seen significant growth. The market, which was valued at $8.23 billion in 2024, is anticipated to increase to $8.69 billion in 2025, representing a compound annual growth rate (CAGR) of 5.5%. This growth over the historical period can be credited to factors such as increased awareness and screening initiatives, a rise in the prevalence of BPH, improved healthcare knowledge, enhancements in healthcare infrastructure, and an expanding elderly population.
The market for treatment of benign prostatic hyperplasia is expected to experience robust growth over the next few years, with predictions of reaching a market size of $10.74 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this projected growth include an increase in the use of less invasive procedures, an aging population, availability of advanced treatments, a greater emphasis on care that focuses on the patient, and a rise in the occurrence of accompanying health issues. Trends anticipated to be seen during this forecast period consist of the development of targeted treatment approaches, implementation of digital health solutions, advances in surgical procedures, integration of 3D imaging for diagnostic purposes, and progress in care models that prioritize the patient.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21112&type=smp
Which Key Factors Are Fueling Growth In The Benign Prostatic Hyperplasia Treatment Market?
The increasing preference for minimally invasive surgeries is forecasted to fuel the benign prostatic hyperplasia treatment market’s expansion. These surgeries involve fewer or no incisions by utilizing unique instruments, thereby reducing pain, recovery duration, and complication risks. The growing popularity of such procedures lies in their inherent advantages, including lesser recovery periods, minimized discomfort, fewer complication risks, and better cosmetic results. The use of minimally invasive procedures in treating benign prostatic hyperplasia results in swifter recovery, lower complication chances, and efficient symptom alleviation, therefore improving the overall surgery results. As an illustration, the American Society of Plastic Surgeons (ASPS), a professional association based in the US, stated that in 2022, there were 23,672,269 cosmetic minimally invasive procedures performed worldwide. The treatments encompassed procedures like neuromodulator injections, lip augmentation, and non-invasive skin tightening. Consequently, the adoption surge of minimally invasive surgeries is propelling the benign prostatic hyperplasia treatment market’s growth.
How Is The Benign Prostatic Hyperplasia Treatment Market Categorized Across Applications And Types?
The benign prostatic hyperplasia treatmentmarket covered in this report is segmented –
1) By Treatment: Minimal Invasive Surgery; Invasive Surgery
2) By Therapeutic Class: Alpha Blockers; 5-Alpha Reductase Inhibitors; Phosphodiesterase-5 Inhibitors; Other Therapeutic classes
3) By End User: Home Healthcare; Hospitals And Clinics; Research And Manufacturing
Subsegments:
1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP); Laser Surgery; Prostatic Urethral Lift; Transurethral Incision of the Prostate (TUIP); Microwave Therapy
2) By Invasive Surgery: Open Prostatectomy; Robotic Prostatectomy
How Are Industry Trends Steering The Expansion Of The Benign Prostatic Hyperplasia Treatment Market?
Leading businesses within the benign prostatic hyperplasia treatment market are focusing on the creation of novel solutions, such as minimally invasive procedures, to improve patient results and decrease recuperation periods. These methods involve little to no incisions, thereby reducing trauma, discomfort, and risks of complications while offering a quicker recovery compared to older surgical treatments. For example, in December 2022, the UroLift System was introduced by Teleflex Incorporated, an American medical device firm, as a treatment option for benign prostatic hyperplasia. This system employs small, permanent implants to relocate enlarged prostate tissue, providing substantial symptom alleviation without the necessity for tissue removal, cutting, or heating. This outpatient procedure guarantees a speedy recovery, maintains sexual performance, and yields superior symptom relief compared to conventional BPH drugs, with side effects usually dissipating within a two to four-week timeframe.
Which Firms Are Making The Biggest Impact In The Benign Prostatic Hyperplasia Treatment Market?
Major companies operating in the benign prostatic hyperplasia treatment market are Pfizer Inc., Merck And Co Inc, AbbVie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Public Limited Company, Medtronic Public Limited Company, Mezzion Pharma Co Ltd, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Boston Scientific Corporation, Astellas Pharma Inc., Olympus Corporation, Coloplast Group, Teleflex Incorporated, Cook Medical Incorporated, AngioDynamics, Inc., HistoSonics Inc, Urovant Sciences Ltd, UroGen Pharma Ltd., Urologix Inc, Zenflow Inc, Butterfly Medical Ltd.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Benign Prostatic Hyperplasia Treatment Market Expansion?
North America was the largest region in the benign prostatic hyperplasia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benign prostatic hyperplasia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21112&type=smp
Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia Treatment Market 2025, By The Business Research Company
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2025
Urinary Stone Treatment Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
